ESMO 2020 Archives - Medical Conferences

Home > Oncology > ESMO 2020

European Society for Medical Oncology 19-21 September 2020

Table of Contents

Featured articles

Letter from the Editor

Editor

Dr Stefan Rauh, Centre Hospitalier Emile Mayrisch, Luxembourg

COVID-19 and Cancer

ESMO 2020 Highlights Podcast

Presented By

Dr Rachel Giles, Medicom

COVID-19 and Cancer

COVID-19 and Cancer

Breast Cancer

CDK4/6 inhibition in high-risk early breast cancer

Neoadjuvant treatment in patients with high-risk early breast cancer

Prognostic value of tumour infiltrating lymphocytes in young TNBC patients

Contradicting results for chemoimmunotherapy in metastatic TNBC

Second-line sacituzumab govitecan improves survival in metastatic TNBC

Gastrointestinal Cancers

Rechallenge of RAS/BRAF wildtype CRC with avelumab plus cetuximab

Surveillance after curative treatment for CRC

Adjuvant chemotherapy less effective in elderly CRC patients

Nivolumab plus chemotherapy: new standard for first-line treatment of gastric cancer?

Lung Cancer

Preoperative immunotherapy in early stage NSCLC safe and feasible

No advantage of post-operative radiotherapy in patients with stage IIIA N2 NSCLC

Adjuvant osimertinib in NSCLC reduces risk of CNS recurrence

Lorlatinib outperforms crizotinib in ALK-positive advanced NSCLC

First-line immune checkpoint inhibition in metastatic NSCLC

PD-L1 density, a new predictive biomarker in NSCLC

Atezolizumab/bevacizumab for non-squamous NSCLC with high PD-L1 expression

Consolidation ipilimumab and nivolumab in limited stage SCLC

Melanoma

Adjuvant immune checkpoint inhibition after complete resection

Immuno-combination therapy in metastatic melanoma

Genitourinary Cancers

Abiraterone in M1 hormone-naïve prostate cancer

New treatment option for patients with mCRPC

First-line treatment of advanced/metastatic RCC

First-line immune-combination therapies in mUC

Second- and third-line treatment options in mUC

Bladder cancer risk and early detection

Presented By

Dr Thibault De La Motte Rouge, Dr Wei Shen Tan, Dr Bas van Rhijn, Dr Francesco Soria

Gynaecological Cancers

Treatment of newly diagnosed ovarian cancer

Treatment of recurrent ovarian cancer

Palbociclib effective in ER-positive endometrial cancer

Basic Science

Bispecific antibodies targeting PD-1 and CTLA-4: new kids on the block(ade)

PD-(L)1, LAG-3, and TIM blockade

CRC disseminates using collective migration